Difference between revisions of "Programmed death-ligand 1"
Jump to navigation
Jump to search
| Line 4: | Line 4: | ||
==General== | ==General== | ||
*[[IHC]] testing using a PD-L1 antibody predicts response to anti-PD-L1 drugs.<ref name=pmid26970723/> | *[[IHC]] testing using a PD-L1 antibody (demonstrating positive tumour cells) predicts response to anti-PD-L1 drugs.<ref name=pmid26970723/> | ||
==Prognosis== | ==Prognosis== | ||